95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.48%
Negative revenue growth while GFI stands at 13.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.48%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
219.35%
EBIT growth above 1.5x GFI's 21.34%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
219.35%
Positive operating income growth while GFI is negative. John Neff might view this as a competitive edge in operations.
311.06%
Net income growth above 1.5x GFI's 20.26%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
975.86%
EPS growth above 1.5x GFI's 21.05%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
975.86%
Diluted EPS growth above 1.5x GFI's 18.75%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
835.87%
OCF growth above 1.5x GFI's 27.35%. David Dodd would confirm a clear edge in underlying cash generation.
835.87%
FCF growth above 1.5x GFI's 50.03%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7.47%
10Y revenue/share CAGR under 50% of GFI's 137.33%. Michael Burry would suspect a lasting competitive disadvantage.
7.47%
5Y revenue/share CAGR under 50% of GFI's 94.05%. Michael Burry would suspect a significant competitive gap or product weakness.
7.47%
3Y revenue/share CAGR under 50% of GFI's 57.40%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.39%
Negative equity/share CAGR over 10 years while GFI stands at 54.65%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.39%
Negative 5Y equity/share growth while GFI is at 109.50%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.39%
Negative 3Y equity/share growth while GFI is at 44.58%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.57%
Our AR growth while GFI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-6.58%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.06%
Asset growth at 50-75% of GFI's 7.05%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.07%
Under 50% of GFI's 16.39%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-148.44%
We cut SG&A while GFI invests at 70.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.